Sunday, November 24, 2024

Mark Schneider

Nestlé plans to introduce a series of meals in the US tailored to complement the use of GLP-1 weight-loss medication.The Swiss corporation stated that the Vital Pursuit products are rich in protein, provide ample fiber, include...
Nestle SA CEO Mark Schneider downplayed the impact of GLP-1 weight-loss drugs on the world's largest food company, emphasizing the company's focus on expanding its range of products with reduced calorie content.In a Bloomberg TV interview,...

Recent articles

× Drop a, Hi?